Proton beam therapy is an advanced form of external radiotherapy that uses high-energy proton beams instead of photon x-ray beams or electrons. Carefully measured doses of protons are delivered to the precise area needing treatment, using the latest IBA ProteusONE technology. This ensures that the delivery of proton beam therapy is highly accurate and prevents the risk of radiation reaching surrounding healthy tissue.
Radiotherapy is used to kill and destroy cancer cells. It utilises radiation in the form of high-energy x-rays, known as photons, to kill and damage the cancerous cells and prevent their growth and reproduction. It can be used as a non-surgical option to treat cancer, and it can also be used to shrink a tumour or in combination with other treatments.
The Rutherford Cancer Centres and Elekta are bringing the next generation of personalised adaptive radiotherapy technology to oncology centres across the UK, with the new MR-linac Elekta Unity now available at the Rutherford Cancer Centre North West in Liverpool.
Dr Robert Campbell is a Senior Consultant in Musculoskeletal Radiology.
He is a member of British Society of Skeletal Radiologists (past secretary & treasurer and current Vice- President), and member of the European Society of Skeletal Radiologists & International Skeletal Society.
He is an author of over 30 peer reviewed publications in Skeletal Radiology and multiple book chapters.
BSSR - Secretary, Treasurer, Vice-President
ESSR - Chair of US committee
ISS - Chair of Poster committee
Dr Robert Campbell does not hold a share or financial interest in the Rutherford Cancer Centres or another Rutherford Health plc company.
Dr Robert Campbell does not have a share or financial interest in equipment used at the Rutherford Cancer Centres or another Rutherford Health plc company.
Dr Robert Campbell does not hold any paid advisory role(s) at the Rutherford Cancer Centres or on behalf of Rutherford Cancer Centres or Rutherford Health plc.